查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948371

2026年全球肿瘤消融设备市场报告

Tumor Ablation Therapy Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，肿瘤消融治疗设备的市场规模迅速扩张，预计将从2025年的8.2亿美元成长到2026年的9.5亿美元，复合年增长率达15.0%。过去几年的成长可归因于多种因素，例如癌症发病率上升、肿瘤治疗中心扩张、微创疗法的普及、先进影像技术的广泛应用以及人们对器官保留疗法的日益青睐。

预计未来几年肿瘤消融设备市场将快速成长，到2030年市场规模将达到16.1亿美元，复合年增长率（CAGR）为14.2%。预测期内的成长将主要受以下因素驱动：精准肿瘤学投资的增加、门诊癌症治疗需求的成长、先进消融技术的推广应用、影像和治疗系统整合程度的提高，以及对个人化癌症治疗的日益重视。预测期内的关键趋势包括：微创肿瘤消融技术的日益普及、影像引导消融系统的广泛应用、对器官特异性消融技术的需求不断增长、经皮治疗方法的拓展，以及对精准肿瘤学的日益重视。

受癌症发生率不断上升的推动，肿瘤消融设备市场正在成长。癌症是主要死因之一，约占全球死亡人数的六分之一。肿瘤消融术是一种微创手术，广泛用于治疗包括肺、肝、肾和骨骼在内的各种部位的肿瘤。例如，根据美国癌症协会（一家总部位于美国的非营利健康组织）估计，2023年美国预计将新增约1,958,310例癌症病例，高于2022年报告的1,918,030例。这种治疗方法为癌症患者提供了一种有效的治疗选择，尤其适用于对化疗或放射线治疗无反应的患者，从而推动了肿瘤消融设备市场的成长。

为了获得竞争优势，肿瘤消融设备市场的主要企业正致力于开发微创疗法。微创疗法因其能够在最大限度减少对周围健康组织损伤的同时，实现精准有效的治疗，而被广泛应用于肿瘤消融领域。例如，2023年8月，美国公司Francis Medical凭藉其微创水蒸气消融疗法乳酪馅饼，获得了美国食品药物管理局（FDA）的突破性医疗器材认定。 Francis Medical是一家为摄护腺癌、肾臟癌和膀胱癌提供微创治疗方案的公司。该认定旨在加速此类医疗设备医疗设备的研发和监管审批，并使患者能够更早获得治疗。 Vanquish利用少量无菌水蒸气中所含的热能，透过简单的经尿道手术将标靶治疗输送到癌组织。该治疗方法旨在有效破坏癌细胞，同时保护周围组织，从而降低传统前列腺癌治疗中常见的严重副作用风险。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球肿瘤消融设备市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧与自主智能
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 永续性、气候技术和循环经济
  • 主要趋势
    • 微创肿瘤消融手术的应用日益增多
    • 影像导引消融系统的应用日益广泛
    • 对器官特异性消融技术的需求日益增长
    • 拓展经皮治疗方法
    • 日益关注精准肿瘤学

第五章 终端用户产业市场分析

  • 医院
  • 肿瘤诊所
  • 专科癌症中心
  • 介入放射中心
  • 学术医疗机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球肿瘤消融设备市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球肿瘤消融设备市场规模、对比及成长率分析
  • 全球肿瘤消融设备市场表现：规模与成长，2020-2025年
  • 全球肿瘤消融设备市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 透过技术
  • 射频消融、微波消融、冷冻消融、不可逆电穿孔消融及其他技术
  • 透过治疗
  • 外科手术、腹腔镜手术、经皮
  • 透过使用
  • 肾癌、肝癌、乳癌、肺癌、摄护腺癌及其他适应症
  • 最终用户
  • 医院、肿瘤诊所和其他最终用户
  • 按类型细分：射频消融术（RFA）
  • 单极射频消融装置，双极射频消融装置
  • 按类型细分：微波消融
  • 高频微波设备、低频微波设备
  • 按类型细分：冷冻消融
  • 液态氮氮基设备，氩气基设备
  • 按类型细分：不可逆电穿孔消融术（IRE）
  • NanoKnife消融系统，高压脉衝产生器
  • 按类型细分：其他技术
  • 雷射消熔设备、超音波导引高强度聚焦超音波（HIFU）和化学消融技术

第十章 区域与国家分析

  • 全球肿瘤消融设备市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球肿瘤消融设备市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 肿瘤消融设备市场：竞争格局及市场占有率（2024年）
  • 肿瘤消融设备市场：公司估值矩阵
  • 肿瘤消融设备市场：公司概况
    • Galil Medical Inc.
    • Misonix Inc.
    • HealthTronics Inc.
    • AngioDynamics Inc.
    • Boston Scientific Corporation

第37章：其他领先和创新企业

  • Medtronic plc, EDAP TMS SA, NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, Theraclion, INTIO Inc., Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年肿瘤消融设备市场：提供新机会的国家
  • 2030年肿瘤消融设备市场：充满新机会的细分市场
  • 2030年肿瘤消融设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MTATD01_G26Q1

Tumor ablation therapy devices are minimally invasive tools used to treat tumors, typically in the kidney, liver, and lung. These devices utilize different techniques to target and destroy cancerous cells while safeguarding the surrounding healthy tissue.

The primary technologies utilized in tumor ablation therapy devices include radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and other related methods. Irreversible electroporation (IRE) is an innovative technique within tumor ablation therapy, involving the application of micro to millisecond electrical pulses to undesired tissue, which results in the induction of cell necrosis through irreversible cell membrane permeabilization. Treatments using these devices can take the form of surgical procedures, laparoscopic interventions, or percutaneous methods, and are applicable in the treatment of various types of cancer, including kidney, liver, breast, lung, prostate, and others. The end-users of tumor ablation therapy devices encompass hospitals, oncology clinics, and other healthcare facilities.

Tariffs are influencing the tumor ablation therapy devices market by increasing costs of imported generators, probes, imaging components, cryogenic systems, and electronic controls. Hospitals and oncology centers in North America and Europe are most affected due to reliance on imported high-value medical equipment, while Asia-Pacific faces higher production and export costs. These tariffs are increasing treatment system prices and extending procurement timelines. However, they are also driving localized device manufacturing, regional assembly operations, and innovation in cost-efficient ablation technologies.

The tumor ablation therapy devices market research report is one of a series of new reports from The Business Research Company that provides tumor ablation therapy devices market statistics, including tumor ablation therapy devices industry global market size, regional shares, competitors with a tumor ablation therapy devices market share, detailed tumor ablation therapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation therapy devices industry. This tumor ablation therapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor ablation therapy devices market size has grown rapidly in recent years. It will grow from $0.82 billion in 2025 to $0.95 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to increasing cancer incidence rates, expansion of oncology treatment centers, rising adoption of minimally invasive therapies, availability of advanced imaging technologies, growing preference for organ-preserving treatments.

The tumor ablation therapy devices market size is expected to see rapid growth in the next few years. It will grow to $1.61 billion in 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increasing investments in precision oncology, rising demand for outpatient cancer treatments, expansion of advanced ablation technologies, growing integration of imaging and therapy systems, increasing focus on personalized cancer care. Major trends in the forecast period include increasing adoption of minimally invasive tumor ablation procedures, rising use of image-guided ablation systems, growing demand for organ-specific ablation technologies, expansion of percutaneous treatment approaches, enhanced focus on precision oncology.

The tumor ablation therapy devices market is experiencing growth driven by the increasing prevalence of cancer. Cancer is a leading cause of mortality, with approximately 1 in 6 deaths worldwide attributed to this disease. Tumor ablation therapy is a minimally invasive procedure widely used to treat various types of tumors, including those in the lung, liver, kidney, and bones. For example, in 2023, the American Cancer Society Inc., a US-based non-profit health organization, estimates that the US will see around 1,958,310 new cancer cases, an increase compared to the more than 1,918,030 new cancer cases in 2022. This procedure offers an effective treatment option, particularly for patients who have not responded to chemotherapy or radiotherapy, thus supporting the growth of the tumor ablation therapy devices market.

Major companies operating in the tumor ablation therapy devices market are focusing on developing minimally invasive therapies to gain a competitive edge. Minimally invasive therapy is widely used in tumor ablation as it enables precise and effective treatment while minimizing damage to surrounding healthy tissues. For instance, in August 2023, Francis Medical Inc., a US-based provider of minimally invasive treatment solutions for prostate, kidney, and bladder cancer, received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Vanquish minimally invasive water vapor ablation therapy. This designation is intended to accelerate the device's development and regulatory review, potentially enabling faster patient access. Vanquish uses the thermal energy contained in a small amount of sterile water vapor to deliver targeted treatment to cancerous tissue through a simple transurethral procedure. The therapy is designed to effectively destroy cancer cells while preserving nearby structures, thereby reducing the risk of severe side effects commonly associated with conventional prostate cancer treatments.

In October 2024, ExcelFin Acquisition Corp, a US-based publicly traded special purpose acquisition company, merged with Betters Medical Investment Holdings Limited (Baird Medical) for an undisclosed amount. Through this merger, ExcelFin plans to take Baird Medical public and support its growth strategy, allowing the company to expand its microwave ablation (MWA) technology portfolio and accelerate its penetration into the U.S. and global markets. Betters Medical Investment Holdings Limited is a China-based medical device company that develops microwave ablation systems for minimally invasive tumor treatment.

Major companies operating in the tumor ablation therapy devices market are Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, Theraclion, INTIO Inc., Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Bovie Medical Corporation,

North America was the largest region in the tumor ablation therapy devices market in 2025. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tumor ablation therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tumor ablation therapy devices market consists of sales of radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and others that are used for tumor ablation therapies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Ablation Therapy Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses tumor ablation therapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor ablation therapy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tumor ablation therapy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Technology: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Irreversible Electroporation Ablation; Other Technologies
  • 2) By Treatment: Surgical; Laparoscopic; Percutaneous
  • 3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Other Applications
  • 4) By End User: Hospitals; Oncology Clinics; Other End Users
  • Subsegments:
  • 1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices; Bipolar RFA Devices
  • 2) By Microwave Ablation: High-frequency Microwave Devices; Low-frequency Microwave Devices
  • 3) By Cryoablation: Liquid Nitrogen-based Devices; Argon Gas-based Devices
  • 4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems; High-voltage Pulse Generators
  • 5) By Other Technologies: Laser Ablation Devices; Ultrasound-guided High-intensity Focused Ultrasound (HIFU); Chemical Ablation Techniques
  • Companies Mentioned: Galil Medical Inc.; Misonix Inc.; HealthTronics Inc.; AngioDynamics Inc.; Boston Scientific Corporation; Medtronic plc; EDAP TMS S.A.; NeuWave Medical Inc.; BVM Medical Limited; Erbe Elektromedizin GmbH; Theraclion; INTIO Inc.; Olympus Corporation; Stryker Corporation; Merit Medical Systems Inc.; Insightec Ltd.; Terumo Corporation; Monteris Medical Corporation; IceCure Medical Ltd.; Profound Medical Inc.; Alpinion Medical Systems Co. Ltd.; Sonacare Medical; Hologic Inc.; Endocare Inc.; Bovie Medical Corporation;
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Tumor Ablation Therapy Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Tumor Ablation Therapy Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Tumor Ablation Therapy Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Tumor Ablation Therapy Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Industry 4.0 And Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.5 Sustainability, Climate Tech And Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Minimally Invasive Tumor Ablation Procedures
    • 4.2.2 Rising Use Of Image-Guided Ablation Systems
    • 4.2.3 Growing Demand For Organ-Specific Ablation Technologies
    • 4.2.4 Expansion Of Percutaneous Treatment Approaches
    • 4.2.5 Enhanced Focus On Precision Oncology

5. Tumor Ablation Therapy Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Oncology Clinics
  • 5.3 Specialty Cancer Centers
  • 5.4 Interventional Radiology Centers
  • 5.5 Academic Medical Institutions

6. Tumor Ablation Therapy Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tumor Ablation Therapy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Tumor Ablation Therapy Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Tumor Ablation Therapy Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Tumor Ablation Therapy Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Tumor Ablation Therapy Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tumor Ablation Therapy Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tumor Ablation Therapy Devices Market Segmentation

  • 9.1. Global Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
  • 9.2. Global Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Surgical, Laparoscopic, Percutaneous
  • 9.3. Global Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
  • 9.4. Global Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Oncology Clinics, Other End Users
  • 9.5. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Radiofrequency Ablation (RFA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Monopolar RFA Devices, Bipolar RFA Devices
  • 9.6. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Microwave Ablation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • High-frequency Microwave Devices, Low-frequency Microwave Devices
  • 9.7. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Cryoablation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liquid Nitrogen-based Devices, Argon Gas-based Devices
  • 9.8. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Irreversible Electroporation Ablation (IRE), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • NanoKnife Ablation Systems, High-voltage Pulse Generators
  • 9.9. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques

10. Tumor Ablation Therapy Devices Market Regional And Country Analysis

  • 10.1. Global Tumor Ablation Therapy Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Tumor Ablation Therapy Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tumor Ablation Therapy Devices Market

  • 11.1. Asia-Pacific Tumor Ablation Therapy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tumor Ablation Therapy Devices Market

  • 12.1. China Tumor Ablation Therapy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tumor Ablation Therapy Devices Market

  • 13.1. India Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tumor Ablation Therapy Devices Market

  • 14.1. Japan Tumor Ablation Therapy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tumor Ablation Therapy Devices Market

  • 15.1. Australia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tumor Ablation Therapy Devices Market

  • 16.1. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tumor Ablation Therapy Devices Market

  • 17.1. South Korea Tumor Ablation Therapy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tumor Ablation Therapy Devices Market

  • 18.1. Taiwan Tumor Ablation Therapy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tumor Ablation Therapy Devices Market

  • 19.1. South East Asia Tumor Ablation Therapy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tumor Ablation Therapy Devices Market

  • 20.1. Western Europe Tumor Ablation Therapy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tumor Ablation Therapy Devices Market

  • 21.1. UK Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tumor Ablation Therapy Devices Market

  • 22.1. Germany Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tumor Ablation Therapy Devices Market

  • 23.1. France Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tumor Ablation Therapy Devices Market

  • 24.1. Italy Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tumor Ablation Therapy Devices Market

  • 25.1. Spain Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tumor Ablation Therapy Devices Market

  • 26.1. Eastern Europe Tumor Ablation Therapy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tumor Ablation Therapy Devices Market

  • 27.1. Russia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tumor Ablation Therapy Devices Market

  • 28.1. North America Tumor Ablation Therapy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tumor Ablation Therapy Devices Market

  • 29.1. USA Tumor Ablation Therapy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tumor Ablation Therapy Devices Market

  • 30.1. Canada Tumor Ablation Therapy Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tumor Ablation Therapy Devices Market

  • 31.1. South America Tumor Ablation Therapy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tumor Ablation Therapy Devices Market

  • 32.1. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tumor Ablation Therapy Devices Market

  • 33.1. Middle East Tumor Ablation Therapy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tumor Ablation Therapy Devices Market

  • 34.1. Africa Tumor Ablation Therapy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Tumor Ablation Therapy Devices Market, Segmentation By Technology, Segmentation By Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tumor Ablation Therapy Devices Market Regulatory and Investment Landscape

36. Tumor Ablation Therapy Devices Market Competitive Landscape And Company Profiles

  • 36.1. Tumor Ablation Therapy Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Tumor Ablation Therapy Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Tumor Ablation Therapy Devices Market Company Profiles
    • 36.3.1. Galil Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Misonix Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. HealthTronics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. AngioDynamics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Tumor Ablation Therapy Devices Market Other Major And Innovative Companies

  • Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, Theraclion, INTIO Inc., Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc.

38. Global Tumor Ablation Therapy Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tumor Ablation Therapy Devices Market

40. Tumor Ablation Therapy Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Tumor Ablation Therapy Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Tumor Ablation Therapy Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Tumor Ablation Therapy Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer